Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,651–6,675 of 7,816 matching trials · page 267 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease NCT01646333 Memory and Problem-Solving Intervention; Supportive Therapy Runs in: United States · 1 site |
NA other |
COMPLETED | 32 | Virginia Commonwealth University OTHER |
2016-01-08 |
|
Computer-based Cognitive Training for Individuals With Parkinson's Disease NCT02225314 Brain Fitness; InSight; Active Control Runs in: United States · 1 site |
NA other |
COMPLETED | 25 | Virginia Commonwealth University OTHER |
2016-01-08 |
|
The Family Caregiver Training Program for Caregivers of People With Dementia NCT02649244 The Family Caregiver Training Program |
PHASE1|PHASE2 other |
COMPLETED | 36 | Nova Southeastern University OTHER |
2016-01-07 |
|
Clinical Trial of Donepezil Between the Naive Group and the Switching Group NCT01023425 donepezil Runs in: South Korea · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 72 | Samsung Medical Center OTHER |
2016-01-06 |
|
Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia NCT01023867 donepezil Runs in: South Korea · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 88 | Samsung Medical Center OTHER |
2016-01-06 |
|
Characteristics of Treatment Responders to Galantamine NCT01029132 galantamine Runs in: South Korea · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 66 | Samsung Medical Center OTHER |
2016-01-06 |
|
Coordinating Center for Caregiver Intervention Trial NCT00177489 multicomponent psychosocial intervention; Control arm Runs in: United States · 5 sites |
NA other |
COMPLETED | 613 | University of Pittsburgh OTHER |
2016-01-05 |
|
Apps to Reduce the Impact That Adverse Events Among Health Professionals NCT02410408 Apps Root Cause Analysis or patient safety ISO certification; infor... Runs in: Spain · 1 site |
NA other |
COMPLETED | 84 | Universidad Miguel Hernandez de Elche OTHER |
2016-01-05 |
|
Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease NCT00479557 ACC-001 + QS-21; ACC-001; QS-21; Placebo: Phosphate buffered saline Runs in: France; Germany; Spain · 24 sites |
PHASE2 other |
COMPLETED | 86 | Pfizer INDUSTRY |
2016-01-01 |
|
Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease NCT00498602 ACC-001 + QS-21; QS-21; Diluent: Phosphate Buffered Saline; ACC-001 Runs in: United States · 27 sites |
PHASE2 other |
COMPLETED | 160 | Pfizer INDUSTRY |
2016-01-01 |
|
Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease NCT00752232 ACC-001; QS-21; ACC-001; QS-21; PBS Runs in: Japan · 10 sites |
PHASE2 other |
COMPLETED | 40 | Pfizer INDUSTRY |
2016-01-01 |
|
Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease NCT00959192 ACC-001; QS-21; QS-21 Runs in: Japan · 9 sites |
PHASE2 other |
COMPLETED | 32 | Pfizer INDUSTRY |
2016-01-01 |
|
A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients NCT00998764 Bapineuzumab 0.5 mg/kg Runs in: Argentina; Australia; Belgium; Chile; Finland; France; It... · 184 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 494 | Pfizer INDUSTRY |
2016-01-01 |
|
Stress Biomarkers Among Patients Undergoing Treatment for Excited Delirium and Severe Pain in the Emergency Department NCT01747824 Runs in: United States · 1 site |
NA other |
COMPLETED | 1,322 | Hennepin Healthcare Research Institute OTHER |
2015-12-23 |
|
PiB PET Scanning in Speech and Language Based Dementias NCT01623284 C-11 PiB; F-18 FDG Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 168 | Mayo Clinic OTHER |
2015-12-22 |
|
Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD NCT01723553 C-11 PiB Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 27 | Mayo Clinic OTHER |
2015-12-21 |
|
Alzheimer Patients and the Snoezelen Program NCT00548951 Snoezelen Room; Snoezelen Room; Control Runs in: Canada · 1 site |
PHASE1 other |
COMPLETED | 18 | Queen's University OTHER |
2015-12-16 |
|
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy NCT01497652 Rasagiline/Placebo; Rasagiline Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 34 | Georgetown University OTHER |
2015-12-16 |
|
Nilotinib in Cognitively Impaired Parkinson Disease Patients 001 NCT02281474 Nilotinib Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 12 | Georgetown University OTHER |
2015-12-16 |
|
A Longitudinal Multidimensional Population Study on Brain Aging NCT01345110 Runs in: Italy · 1 site |
NA other |
COMPLETED | 1,321 | Fondazione Golgi Cenci OTHER |
2015-12-11 |
|
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease NCT00704782 dimebon Runs in: United States · 4 sites |
PHASE2 symptomatic-cholinergic |
TERMINATED | 50 | Medivation, Inc. INDUSTRY |
2015-12-10 |
|
Effects of Mental Stimulation in Patients With Mild Cognitive Impairment NCT01212692 mentally stimulating activities Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 63 | Johns Hopkins University OTHER |
2015-12-09 |
|
IGF and Other Neurotrophic Factors in Patients With Dementia NCT02271750 lumbar puncture Runs in: Denmark · 1 site |
NA other |
COMPLETED | 120 | University of Aarhus OTHER |
2015-12-08 |
|
A Naturalistic Two-year Cohort Study of Agitation and Quality of Life in Care Homes NCT02216396 Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 1,734 | University College, London OTHER |
2015-12-04 |
|
Trial of a Medical and Mental Health Unit for Older People NCT01136148 A medical and mental health unit Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 600 | University of Nottingham OTHER |
2015-12-03 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial